Lugano Financial Advisors SA (LFA)’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-150
Closed -$10.3K – 184
2024
Q2
$10.3K Hold
150
– – 0.01% 163
2024
Q1
$11K Hold
150
– – 0.01% 155
2023
Q4
$12.2K Hold
150
– – 0.01% 154
2023
Q3
$11.2K Hold
150
– – 0.01% 146
2023
Q2
$11.6K Buy
+150
New +$12K 0.01% 160
2020
Q3
– Sell
-2,760
Closed -$207K – 116
2020
Q2
$207K Hold
2,760
– – 0.22% 60
2020
Q1
$174K Hold
2,760
– – 0.16% 71
2019
Q4
$179K Buy
+2,760
New +$180K 0.13% 74
2019
Q2
$186K Hold
2,760
– – 0.12% 74
2019
Q1
$179K Hold
2,760
– – 0.11% 74
2018
Q4
$213K Hold
2,760
– – 0.15% 74
2018
Q3
$213K Buy
2,760
+1,544
+127% +$117K 0.15% 74
2018
Q2
$86K Buy
+1,216
New +$85.9K 0.08% 88

Other funds holding GILD

Lugano Financial Advisors SA (LFA)'s GILD Position: Q3 2024 in Review

Lugano Financial Advisors SA (LFA) sold out of Gilead Sciences (GILD) in Q3 2024, closing a stake of 150 shares — an estimated $10.3K sold.

Lugano Financial Advisors SA (LFA) first reported a position in GILD in Q2 2018 and held it in 13 quarters. The position peaked at $213K in Q4 2018. 1,721 funds tracked by Wall St. Rank hold GILD as of Q3 2024.

  • Lugano Financial Advisors SA (LFA) reported no remaining Gilead Sciences position as of Q3 2024 after selling out during the quarter.
  • Lugano Financial Advisors SA (LFA) sold 150 Gilead Sciences shares in Q3 2024, an estimated $10.3K.
  • Lugano Financial Advisors SA (LFA) first reported a position in Gilead Sciences in Q2 2018 and held it in 13 quarters.
  • Lugano Financial Advisors SA (LFA)'s Gilead Sciences position peaked at $213K in Q4 2018.
  • 1,721 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2024.

Based on Lugano Financial Advisors SA (LFA)'s 13F filing for Q3 2024, filed 7 Nov 2024.